Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study

1Department of Genomic Medicine, Institute of Human Development, Manchester Academic Health Science Centre (MAHSC), Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK 2Institute of Population Health, Centre for Imaging Sciences, University of Manchester, Manchester, UK 3The Nightingale Centre and Genesis Prevention Centre, University Hospital of South Manchester, Manchester, UK 4Department of Health Economics, University of Manchester, Manchester, UK 5Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK 6Patient representative

[1]  Malcolm C Pike,et al.  Does mammographic density reflect ethnic differences in breast cancer incidence rates? , 2004, American journal of epidemiology.

[2]  M. Skolnick,et al.  Inheritance of proliferative breast disease in breast cancer kindreds. , 1990, Science.

[3]  Jennifer A. Harvey,et al.  Comparing a New Volumetric Breast Density Method (VolparaTM) to Cumulus , 2010, Digital Mammography / IWDM.

[4]  D. Evans,et al.  Assessing women at high risk of breast cancer: a review of risk assessment models. , 2010, Journal of the National Cancer Institute.

[5]  Vipat Kuruchittham,et al.  The Wisconsin Breast Cancer Epidemiology Simulation Model. , 2006, Journal of the National Cancer Institute. Monographs.

[6]  X. Castells,et al.  Cost-effectiveness of early detection of breast cancer in Catalonia (Spain) , 2011, BMC Cancer.

[7]  Maureen A Smith,et al.  Retrospective cost-effectiveness analysis of screening mammography. , 2006, Journal of the National Cancer Institute.

[8]  A. Howell,et al.  Familial breast cancer. , 1994, BMJ.

[9]  Hans Joenje,et al.  Biallelic Inactivation of BRCA2 in Fanconi Anemia , 2002, Science.

[10]  Opper,et al.  HERITABILITY OF MAMMOGRAPHIC DENSITY, A RISK FACTOR FOR BREAST CANCER , 2002 .

[11]  Paul Kind,et al.  UK population norms for EQ-5D , 1999 .

[12]  E. Pisano,et al.  Cost-effectiveness of digital mammography breast cancer screening. , 2008, Annals of internal medicine.

[13]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[14]  D. Gudbjartsson,et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.

[15]  A. Howell,et al.  Uptake of Risk-Reducing Surgery in Unaffected Women at High Risk of Breast and Ovarian Cancer Is Risk, Age, and Time Dependent , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[16]  David Moher,et al.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement , 2013, Cost Effectiveness and Resource Allocation.

[17]  Harry J de Koning,et al.  Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. , 2008, Journal of the National Cancer Institute.

[18]  B. Pasche,et al.  New Insights into Breast Cancer Genetics and Impact on Patient Management , 2007, Current treatment options in oncology.

[19]  G. Leung,et al.  What is the most cost-effective population-based cancer screening program for Chinese women? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Deborah Hughes,et al.  Genome-wide association study identifies five new breast cancer susceptibility loci , 2010, Nature Genetics.

[21]  S. Cummings,et al.  Single x-ray absorptiometry method for the quantitative mammographic measure of fibroglandular tissue volume. , 2009, Medical physics.

[22]  D. Bowen,et al.  Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  Susan M. Astley,et al.  Volumetric and Area-Based Measures of Mammographic Density in Women with and without Cancer , 2012, Digital Mammography / IWDM.

[24]  R. Warren,et al.  Eligibility for Magnetic Resonance Imaging Screening in the United Kingdom: Effect of Strict Selection Criteria and Anonymous DNA Testing on Breast Cancer Incidence in the MARIBS Study , 2009, Cancer Epidemiology Biomarkers & Prevention.

[25]  M. Moskowitz.  Cost‐benefit determinations in screening mammography , 1987, Cancer.

[26]  J. Wolfe.  Risk for breast cancer development determined by mammographic parenchymal pattern , 1976, Cancer.

[27]  Anthony Howell,et al.  Breast cancer risk-assessment models , 2007, Breast Cancer Research.

[28]  D. Berry,et al.  Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. , 1998, American journal of human genetics.

[29]  S. Feig.  Mammographic screening of women aged 40–49 years. Benefit, risk, and cost considerations , 1995, Cancer.

[30]  J. Brazier,et al.  Health-state utility values in breast cancer , 2010, Expert review of pharmacoeconomics & outcomes research.

[31]  C. Mathew,et al.  Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer , 2007, Nature Genetics.

[32]  Deborah Hughes,et al.  Germline mutations in RAD51D confer susceptibility to ovarian cancer , 2011, Nature Genetics.

[33]  R. Hubbard,et al.  Assessing Health Care Use and Cost Consequences of a New Screening Modality: The Case of Digital Mammography , 2012, Medical care.

[34]  Ahmedin Jemal,et al.  Trends in Breast Cancer by Race and Ethnicity: Update 2006 , 2006, CA: a cancer journal for clinicians.

[35]  The Polish Breast Cancer Consortium.  Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002 .

[36]  Nazneen Rahman,et al.  ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles , 2006, Nature Genetics.

[37]  N Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.

[38]  C Caldas,et al.  Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. , 2001, Gastroenterology.

[39]  Julian Peto,et al.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.

[40]  A. Howell,et al.  Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family , 2008, BMC Cancer.

[41]  R. Eeles,et al.  Eligibility for MRI screening in the UK: Effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS study , 2009 .

[42]  R. Warren,et al.  Mammography screening: an incremental cost effectiveness analysis of two view versus one view procedures in London. , 1995, Journal of epidemiology and community health.

[43]  Iain Buchan,et al.  Correcting for rater bias in scores on a continuous scale, with application to breast density , 2013, Statistics in medicine.

[44]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[45]  M. Moskowitz,et al.  Cost analysis of aggressive breast cancer screening. , 1979, Radiology.

[46]  P. Arveux,et al.  Building a model to determine the cost-effectiveness of breast cancer screening in France. , 2003, European journal of cancer care.

[47]  S. Cummings,et al.  Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. , 2007, Endocrine-related cancer.

[48]  J. Benítez,et al.  The complex genetic landscape of familial breast cancer , 2013, Human Genetics.

[49]  Andrew N Freedman,et al.  Cancer risk prediction models: a workshop on development, evaluation, and application. , 2005, Journal of the National Cancer Institute.

[50]  C. Jacobi,et al.  Risk Estimation for Healthy Women from Breast Cancer Families , 2004, Cancer Epidemiology Biomarkers & Prevention.

[51]  J Benichou,et al.  Validation studies for models projecting the risk of invasive and total breast cancer incidence. , 1999, Journal of the National Cancer Institute.

[52]  R. Hoover,et al.  Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. , 2000, JAMA.

[53]  J. Haines,et al.  Genome-wide association study identifies a novel breast cancer susceptibility locus at 6q25.1 , 2009, Nature Genetics.

[54]  D. F. Easton,et al.  Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families , 1993 .

[55]  M. Rowland,et al.  Self-reported weight and height. , 1990, The American journal of clinical nutrition.

[56]  J. Bulliard,et al.  Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[57]  M. Thun,et al.  Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 , 2009, Nature Genetics.

[58]  P. Forrest,et al.  Breast cancer screening : report to the Health Ministers of England, Wales, Scotland & Northern Ireland , 1986 .

[59]  Wayne Nelson,et al.  Hazard Plotting for Incomplete Failure Data , 1969 .

[60]  J Brown,et al.  Two view mammography at incident screens: cost effectiveness analysis of policy options , 1999, BMJ.

[61]  I. Buchan,et al.  Ovarian cancer among 8005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2 , 2013, Journal of Medical Genetics.

[62]  G. Mooney.  Breast cancer screening. A study in cost-effectiveness analysis. , 1982, Social science & medicine.

[63]  On the role of arbitration of discordant double readings of screening mammography: experience from two Italian programmes , 2011, La radiologia medica.

[64]  Nico Karssemeijer,et al.  Robust Breast Composition Measurement - VolparaTM , 2010, Digital Mammography / IWDM.

[65]  J. Richardson,et al.  A cost utility analysis of mammography screening in Australia. , 1992, Social science & medicine.

[66]  Susan M. Astley,et al.  A New Step-Wedge for the Volumetric Measurement of Mammographic Density , 2006, Digital Mammography / IWDM.

[67]  C M Rutter,et al.  Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. , 2001, JAMA.

[68]  S. Cummings,et al.  Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. , 2003, Journal of the National Cancer Institute.

[69]  R. Baker,et al.  Use of a mathematical model to evaluate breast cancer screening policy , 1998, Health care management science.

[70]  S. Seal,et al.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.

[71]  D. Schopper,et al.  Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland. , 2009, European journal of cancer.

[72]  Anna Chiarelli,et al.  Body Size, Mammographic Density, and Breast Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[73]  E. Fishell,et al.  Radio-free America: what to do with the waste. , 1994, Environmental health perspectives.

[74]  Mark Sculpher,et al.  Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[75]  Adriano Decarli,et al.  Risk factor modification and projections of absolute breast cancer risk. , 2011, Journal of the National Cancer Institute.

[76]  Mary Wilson,et al.  Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view , 2008, Breast Cancer Research.

[77]  M E Cohen,et al.  Mammographic parenchymal patterns in Asian and Caucasian women attending for screening. , 1993, Clinical radiology.

[78]  D. Easton,et al.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.

[79]  S. Seal,et al.  Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. , 1999, Journal of the National Cancer Institute.

[80]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[81]  Nazneen Rahman,et al.  The emerging landscape of breast cancer susceptibility , 2007, Nature Genetics.

[82]  B. Cowling,et al.  Optimizing resource allocation for breast cancer prevention and care among Hong Kong Chinese women , 2012, Cancer.

[83]  K. Rothman,et al.  Family history of later-onset breast cancer, breast healthy behavior and invasive breast cancer among postmenopausal women: a cohort study , 2010, Breast Cancer Research.

[84]  S. Seal,et al.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene , 2007, Nature Genetics.

[85]  Valerie Beral,et al.  Breast cancer and hormone-replacement therapy in the Million Women Study , 2003, The Lancet.

[86]  F. Lalloo,et al.  Development of a scoring system to screen for BRCA1/2 mutations. , 2010, Methods in molecular biology.

[87]  A. Howell,et al.  The impact of genetic counselling on risk perception in women with a family history of breast cancer. , 1994, British Journal of Cancer.

[88]  M. Gail.  Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model. , 2009, Journal of the National Cancer Institute.

[89]  R. Wilkins.  Polygenes, risk prediction, and targeted prevention of breast cancer. , 2008, The New England journal of medicine.

[90]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[91]  E Goyder,et al.  A review and critique of modelling in prioritising and designing screening programmes. , 2007, Health technology assessment.

[92]  S. Duffy,et al.  Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer , 2013, Breast Cancer Research.

[93]  C. Polanczyk,et al.  Is Age-targeted full-field digital mammography screening cost-effective in emerging countries? A micro simulation model , 2013, SpringerPlus.

[94]  B. Ponder,et al.  Allele-Specific Up-Regulation of FGFR2 Increases Susceptibility to Breast Cancer , 2008, PLoS biology.

[95]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[96]  A. Cook,et al.  Quantifying the natural history of breast cancer , 2013, British Journal of Cancer.

[97]  W. Blattner,et al.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome , 1990, Nature.

[98]  F. Lalloo,et al.  Is multiple SNP testing in BRCA2 and BRCA1 female carriers ready for use in clinical practice? Results from a large Genetic Centre in the UK , 2013, Clinical genetics.

[99]  Greg S. Hurlock,et al.  Computer-aided detection of breast cancer: a cost-effectiveness study. , 2006, Radiology.

[100]  F. Antoñanzas,et al.  Economic evaluation of a mammography-based breast cancer screening programme in Spain , 1997 .

[101]  P. Ganz,et al.  Agreement between breast cancer risk estimation methods. , 1996, Journal of the National Cancer Institute.

[102]  D. Sgroi,et al.  BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function , 2001, Cell.

[103]  C. Ahern,et al.  Cost-Effectiveness Analysis of Mammography and Clinical Breast Examination Strategies: A Comparison with Current Guidelines , 2009, Cancer Epidemiology Biomarkers & Prevention.

[104]  P. Craft,et al.  Cost and cost‐effectiveness of digital mammography compared with film‐screen mammography in Australia , 2009, Australian and New Zealand journal of public health.

[105]  J. Wolfe.  Breast parenchymal patterns and their changes with age. , 1976, Radiology.

[106]  C. Hudis,et al.  Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women , 2011, Breast Cancer Research and Treatment.

[107]  J. Cuzick,et al.  Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK , 2014, British Journal of Cancer.

[108]  K. Ohnuki,et al.  Cost‐effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40–49 years , 2006, Cancer science.

[109]  G A Colditz,et al.  Dual effects of weight and weight gain on breast cancer risk. , 1997, JAMA.

[110]  S. Chanock,et al.  Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status , 2008, Clinical Cancer Research.

[111]  L. Green,et al.  The danger of applying uniform clinical policies across populations: the case of breast cancer in American Indians. , 1994, American journal of public health.

[112]  Ralph Highnam,et al.  Age and Ethnic Differences in Volumetric Breast Density in New Zealand Women: A Cross-Sectional Study , 2013, PloS one.

[113]  Susan M. Astley,et al.  Assessment of change in breast density: reader performance using synthetic mammographic images , 2012, Medical Imaging.

[114]  M. King,et al.  Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 , 2003, Science.

[115]  Nico Karssemeijer,et al.  Volumetric breast density estimation from full-field digital mammograms , 2006, IEEE Trans. Medical Imaging.

[116]  D. Altman,et al.  Measuring agreement in method comparison studies , 1999, Statistical methods in medical research.

[117]  J. Pankow,et al.  Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. , 1997, Journal of the National Cancer Institute.

[118]  Daniel Kopans,et al.  Racial differences in mammographic breast density , 2003, Cancer.

[119]  Zhao Chen,et al.  Ethnicity and breast cancer: factors influencing differences in incidence and outcome. , 2005, Journal of the National Cancer Institute.

[120]  Karla Kerlikowske,et al.  Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model , 2008, Annals of Internal Medicine.

[121]  J. Klijn,et al.  The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. , 2003, American journal of human genetics.

[122]  D. Miglioretti,et al.  Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. , 2007, Journal of the National Cancer Institute.

[123]  Susan M. Astley,et al.  Same task, same observers, different values: the problem with visual assessment of breast density , 2013, Medical Imaging.

[124]  C. Prives,et al.  The Chk2 protein kinase. , 2004, DNA repair.

[125]  E. Swart,et al.  Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany. , 1997, Journal of epidemiology and community health.

[126]  M. Pike,et al.  Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. , 2000, Journal of the National Cancer Institute.

[127]  Christi J. van Asperen,et al.  Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? , 2009, Breast Cancer Research and Treatment.

[128]  H. Sintonen,et al.  The cost‐effectiveness of nationwide breast carcinoma screening in Finland, 1987–1992 , 1999, Cancer.

[129]  W. Dupont,et al.  Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. , 1989, Human pathology.

[130]  J. Rommens,et al.  The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds , 1996, Nature Genetics.

[131]  D. Easton,et al.  The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30–49 , 2007, The European Journal of Health Economics.

[132]  J. Hopper,et al.  The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions , 2008, British Journal of Cancer.

[133]  Paul D P Pharoah,et al.  Cost effectiveness of the NHS breast screening programme: life table model , 2013, BMJ.

[134]  D. Hunter,et al.  Simulation modeling of change to breast cancer detection age eligibility recommendations in Ontario, 2002-2021. , 2004, Cancer detection and prevention.

[135]  A. Wallgren,et al.  BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer – a population based study from the Western Sweden Health Care region , 2010, Acta oncologica.

[136]  Unlocking the value of personalised healthcare in Europe—breast cancer stratification , 2012 .

[137]  J. Kaufhold,et al.  A calibration approach to glandular tissue composition estimation in digital mammography. , 2002, Medical physics.

[138]  Beth A Reboussin,et al.  Postmenopausal hormone therapy and change in mammographic density. , 2003, Journal of the National Cancer Institute.

[139]  D.,et al.  Regression Models and Life-Tables , 2022 .

[140]  J. Cauley,et al.  Body Mass Index and the Risk for Developing Invasive Breast Cancer among High-Risk Women in NSABP P-1 and STAR Breast Cancer Prevention Trials , 2012, Cancer Prevention Research.

[141]  Christiana Kartsonaki,et al.  Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. , 2011, Human molecular genetics.

[142]  S. Duffy,et al.  Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. , 2011, Journal of the National Cancer Institute.

[143]  Susan M. Astley,et al.  Ethnic Variation in Volumetric Breast Density , 2012, Digital Mammography / IWDM.

[144]  D M Parkin,et al.  16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 , 2011, British Journal of Cancer.

[145]  Susan M. Astley,et al.  Estimating Individual Cancer Risks in the UK National Breast Screening Programme: A Feasibility Study , 2008, Digital Mammography / IWDM.

[146]  A. Howell,et al.  Perception of risk in women with a family history of breast cancer. , 1993, British Journal of Cancer.

[147]  B. Cowling,et al.  Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling. , 2010, Hong Kong medical journal = Xianggang yi xue za zhi.

[148]  P. Hartge,et al.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.

[149]  S. Cummings,et al.  Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. , 1999, JAMA.

[150]  J. Otten,et al.  Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands , 2007, Breast Cancer Research and Treatment.

[151]  S. Thacker,et al.  A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer , 1991 .

[152]  Norman E. Breslow,et al.  The design and analysis of cohort studies , 1987 .

[153]  Harry J de Koning,et al.  The MISCAN-Fadia continuous tumor growth model for breast cancer. , 2006, Journal of the National Cancer Institute. Monographs.

[154]  S. Golder,et al.  Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment , 2012, PharmacoEconomics.

[155]  Ralph Highnam,et al.  Volumetric Assessment of Breast Tissue Composition from FFDM Images , 2008, Digital Mammography / IWDM.

[156]  S. Seal,et al.  A genome wide linkage search for breast cancer susceptibility genes , 2006, Genes, chromosomes & cancer.

[157]  Susan M. Astley,et al.  Factors Affecting Agreement between Breast Density Assessment Using Volumetric Methods and Visual Analogue Scales , 2014, Digital Mammography / IWDM.

[158]  I. Buchan,et al.  Prevention of breast cancer in the context of a national breast screening programme , 2012, Journal of internal medicine.

[159]  D. Bentley,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.

[160]  Klemen Rojnik,et al.  Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[161]  H. Feigelson,et al.  Weight loss and postmenopausal breast cancer in a prospective cohort of overweight and obese US women , 2011, Cancer Causes & Control.

[162]  Roger B. Davis,et al.  Racial and ethnic disparities in cancer screening the importance of foreign birth as a barrier to care , 2003, Journal of General Internal Medicine.

[163]  Karla Kerlikowske,et al.  Prospective breast cancer risk prediction model for women undergoing screening mammography. , 2006, Journal of the National Cancer Institute.

[164]  N Risch,et al.  Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.

[165]  J. Norum,et al.  Breast cancer screening by mammography in Norway. Is it cost-effective? , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[166]  Konstantin Strauch,et al.  Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance , 2012, Breast Cancer Research.

[167]  Brian Drohan,et al.  Which Risk Model to Use? Clinical Implications of the ACS MRI Screening Guidelines , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[168]  Dieter Niederacher,et al.  Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene , 2010, Nature Genetics.

[169]  G. Giles,et al.  Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[170]  N. Wald,et al.  UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening , 1995, BMJ.

[171]  M. Badzioch,et al.  Familial breast cancer risks. Effects of prostate and other cancers , 1993, Cancer.

[172]  A. Miller,et al.  Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. , 1995, Journal of the National Cancer Institute.

[173]  A. Howell,et al.  Breast cancer susceptibility variants alter risks in familial disease , 2009, Journal of Medical Genetics.

[174]  R. Scott,et al.  Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. , 2001, American journal of human genetics.

[175]  Jinbo Chen,et al.  Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. , 2006, Journal of the National Cancer Institute.

[176]  D Spiegelman,et al.  Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. , 2001, Journal of the National Cancer Institute.

[177]  Risto Tuominen,et al.  Incremental cost‐effectiveness of double‐reading mammograms , 2004, Breast Cancer Research and Treatment.

[178]  Suet Yi Leung,et al.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 , 2009, Nature Genetics.

[179]  M. Leppert,et al.  Localization of an ataxia-telangiectasia gene to chromosome 11q22–23 , 1988, Nature.

[180]  M. King,et al.  Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.

[181]  Nandita Mitra,et al.  Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families. , 2005, Journal of the National Cancer Institute.

[182]  N. Rahman,et al.  A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO , 2004, Journal of Medical Genetics.

[183]  A. Sigurdsson,et al.  Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer , 2008, Nature Genetics.

[184]  S. Cummings,et al.  Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness , 2011, Annals of Internal Medicine.

[185]  Svetlana Popova,et al.  Cost-Effectiveness Analysis : Breast Cancer Screening Policies for a Safety-Net Program , 2013 .

[186]  Y. Shiloh.  The ATM-mediated DNA-damage response: taking shape. , 2006, Trends in biochemical sciences.

[187]  John Cairns,et al.  Is computer aided detection (CAD) cost effective in screening mammography? A model based on the CADET II study , 2011, BMC health services research.

[188]  S. Cantor,et al.  BACH1 is a DNA repair protein supporting BRCA1 damage response , 2006, Oncogene.

[189]  Douglas F Easton,et al.  Cancer Incidence in BRCA1 mutation carriers. , 2002, Journal of the National Cancer Institute.

[190]  P. Gregersen,et al.  Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33 , 2008, Proceedings of the National Academy of Sciences.

[191]  P. Coyte,et al.  Cost-Effectiveness Analysis of a Screening Program for Breast Cancer in Vietnam. , 2013, Value in health regional issues.

[192]  A. Howell,et al.  Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer , 2001, Journal of medical genetics.

[193]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[194]  Norman Boyd,et al.  A longitudinal study of the effects of menopause on mammographic features. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[195]  J. Fraumeni,et al.  Follow-up study of twenty-four families with Li-Fraumeni syndrome. , 1991, Cancer research.

[196]  A. Gerhardus,et al.  Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review , 2007, European Journal of Human Genetics.

[197]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[198]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007 .

[199]  D. Easton,et al.  Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers , 2006, Breast Cancer Research.

[200]  S Ciatto,et al.  Independent Double Reading of Screening Mammograms , 1995, Journal of medical screening.

[201]  Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. , 2000 .

[202]  R. Boer,et al.  Cost Effectiveness of Shortening Screening Interval or Extending Age Range of NHS Breast Screening Programme , 1999 .

[203]  D. Evans,et al.  Risk assessment and management of high risk familial breast cancer , 2002, Journal of medical genetics.

[204]  J. Donohue,et al.  Ductal Carcinoma in Situ of the Breast , 1997, Annals of Internal Medicine.

[205]  Seung Il Kim,et al.  Personalized Medicine in Breast Cancer: A Systematic Review , 2012, Journal of breast cancer.

[206]  B. Cowling,et al.  Cost effectiveness of mammography screening for Chinese women , 2007, Cancer.

[207]  N. Devlin,et al.  The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand. , 1996, Health policy.

[208]  Susan M. Astley,et al.  Automated Breast Tissue Measurement of Women at Increased Risk of Breast Cancer , 2006, Digital Mammography / IWDM.

[209]  J M Bland,et al.  Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .

[210]  M. King,et al.  Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[211]  D. Easton,et al.  The BOADICEA model of genetic susceptibility to breast and ovarian cancer , 2004, British Journal of Cancer.

[212]  N. Risch,et al.  The calculation of breast cancer risk for women with a first degree family history of ovarian cancer , 1993, Breast Cancer Research and Treatment.

[213]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[214]  H. D. de Koning,et al.  How cost-effective is breast cancer screening in different EC countries? , 1993, European journal of cancer.

[215]  J. Peto,et al.  High constant incidence in twins and other relatives of women with breast cancer , 2000, Nature Genetics.

[216]  Manuela Durando,et al.  A first evaluation of breast radiological density assessment by QUANTRA software as compared to visual classification. , 2012, Breast.

[217]  Richard G. White,et al.  Calibrating Models in Economic Evaluation , 2012, PharmacoEconomics.

[218]  S. Astley,et al.  Single reading with computer-aided detection for screening mammography. , 2008, The New England journal of medicine.

[219]  G. Sakorafas,et al.  Risk estimation for breast cancer development; a clinical perspective. , 2002, Surgical oncology.

[220]  W. Willett,et al.  Adult weight change and risk of postmenopausal breast cancer. , 2006, JAMA.

[221]  Pramodita Sharma.  2012 , 2013, Les 25 ans de l’OMC: Une rétrospective en photos.

[222]  R. Baltussen,et al.  Costs, effects and cost‐effectiveness of breast cancer control in Ghana , 2012, Tropical medicine & international health : TM & IH.

[223]  C. J. Rosenquist,et al.  Screening mammography in women aged 40-49 years: analysis of cost-effectiveness. , 1994, Radiology.

[224]  J. Caro,et al.  Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[225]  J. Cairns,et al.  Cost-effectiveness of non-consensus double reading , 1998 .

[226]  D. Evans.  Genetic predisposition and breast screening , 2013 .

[227]  E. Burnside,et al.  The impact of alternative practices on the cost and quality of mammographic screening in the United States. , 2001, Clinical breast cancer.

[228]  Russell Davies,et al.  Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2006, Cancer research.

[229]  R. Warren,et al.  Mammography screening: an incremental cost effectiveness analysis of double versus single reading of mammograms , 1996, BMJ.

[230]  Jaana M. Hartikainen,et al.  A common coding variant in CASP8 is associated with breast cancer risk , 2007, Nature Genetics.

[231]  R. Goldbohm,et al.  Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease , 2001, The Lancet.

[232]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[233]  Mads Thomassen,et al.  Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. , 2010, Cancer research.

[234]  H. D. de Koning,et al.  A longer breast carcinoma screening interval for women age older than 65 years? , 1999, Cancer.

[235]  Mary Wilson,et al.  Assessing Individual Breast Cancer Risk within the U.K. National Health Service Breast Screening Program: A New Paradigm for Cancer Prevention , 2012, Cancer Prevention Research.

[236]  K. Choi,et al.  The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective? , 2013, Asian Pacific journal of cancer prevention : APJCP.

[237]  Giovanni Parmigiani,et al.  A Model-Based Comparison of Breast Cancer Screening Strategies: Mammograms and Clinical Breast Examinations , 2005, Cancer Epidemiology Biomarkers & Prevention.

[238]  S. Moss,et al.  Routine breast screening for women aged 65–69: results from evaluation of the demonstration sites , 2001, British Journal of Cancer.

[239]  Natasha K. Stout,et al.  Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model , 2006 .

[240]  R. Baltussen,et al.  Cost-Effectiveness Analysis of Breast Cancer Control Interventions in Peru , 2013, PloS one.

[241]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[242]  P. Taylor,et al.  Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography. , 2005, Health technology assessment.

[243]  David A. Hinds,et al.  Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information , 2010, Journal of the National Cancer Institute.

[244]  P. Narula.  MAMMOGRAPHIC DENSITY AND THE RISK AND DETECTION OF BREAST CANCER , 2016 .

[245]  Genica,et al.  Commonly studied single-nucleotide polymorphisms and breast cancer: Results from the Breast Cancer Association Consortium , 2006 .

[246]  B. Knoppers,et al.  Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer , 2006, Journal of Medical Genetics.

[247]  S. Ciatto,et al.  Negligible Advantages and Excess Costs of Routine Addition of Breast Ultrasonography to Mammography in Dense Breasts , 2007, Tumori.

[248]  A. Leitch,et al.  Limitations of the Gail Model in the Specialized Breast Cancer Risk Assessment Clinic , 2002, The breast journal.

[249]  Leif E. Peterson,et al.  Characterization of BRCA1 and BRCA2 mutations in a large United States sample. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[250]  A Howell,et al.  Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme , 2003, Journal of medical genetics.

[251]  C. J. Rosenquist,et al.  The cost-effectiveness of mammographic screening strategies. , 1995, JAMA.

[252]  SM Astley,et al.  PB.17: Inter-observer agreement in visual analogue scale assessment of percentage breast density , 2013, Breast Cancer Research.

[253]  Susan M. Astley,et al.  Use of Volumetric Breast Density Measures for the Prediction of Weight and Body Mass Index , 2014, Digital Mammography / IWDM.

[254]  John S Witte,et al.  Turning of COGS moves forward findings for hormonally mediated cancers , 2013, Nature Genetics.

[255]  H. D. de Koning,et al.  Breast cancer screening and cost‐effectiveness; Policy alternatives, quality of life considerations and the possible impact of uncertain factors , 1991, International journal of cancer.

[256]  C. Mathew,et al.  The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J , 2005, Nature Genetics.

[257]  I. Buchan,et al.  Increased Rate of Phenocopies in All Age Groups in BRCA1/BRCA2 Mutation Kindred, but Increased Prospective Breast Cancer Risk Is Confined to BRCA2 Mutation Carriers , 2013, Cancer Epidemiology, Biomarkers and Prevention.

[258]  Karla Kerlikowske,et al.  Agreement of Mammographic Measures of Volumetric Breast Density to MRI , 2013, PloS one.

[259]  J. Habbema,et al.  A model‐based analysis of the hip project for breast cancer screening , 1990, International journal of cancer.

[260]  C A Kelsey,et al.  Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. , 1998, Radiology.

[261]  W. Foulkes,et al.  Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. , 1999, Journal of the National Cancer Institute.

[262]  K. Kerlikowske,et al.  Cost-Effectiveness of Extending Screening Mammography Guidelines To Include Women 40 to 49 Years of Age , 1997, Annals of Internal Medicine.

[263]  D. Evans,et al.  Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening , 2007, Journal of Medical Genetics.

[264]  Julian Peto,et al.  Association of Genetic Variants at 8q24 with Breast Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.

[265]  P. Clarke,et al.  Cost-benefit analysis and mammographic screening: a travel cost approach. , 1998, Journal of health economics.

[266]  A. Howell,et al.  Mechanisms of Disease: prediction and prevention of breast cancer—cellular and molecular interactions , 2005, Nature Clinical Practice Oncology.

[267]  J. Wolfe,et al.  Mammographic features and breast cancer risk: effects with time, age, and menopause status. , 1995, Journal of the National Cancer Institute.

[268]  D. Gyrd-Hansen.  COST-BENEFIT ANALYSIS OF MAMMOGRAPHY SCREENING IN DENMARK BASED ON DISCRETE RANKING DATA , 2000, International Journal of Technology Assessment in Health Care.

[269]  N F Boyd,et al.  Mammographic densities and breast cancer risk. , 1998, Breast disease.

[270]  J. Cuzick,et al.  Value of Phenotypic and Single-Nucleotide Polymorphism Panel Markers in Predicting the Risk of Breast Cancer , 2013 .

[271]  V. Shane Pankratz,et al.  Mammographic Breast Density as a General Marker of Breast Cancer Risk , 2007, Cancer Epidemiology Biomarkers & Prevention.

[272]  J. Wolfe.  Breast patterns as an index of risk for developing breast cancer. , 1976, AJR. American journal of roentgenology.

[273]  Julian Peto,et al.  Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies , 1996, The Lancet.

[274]  Nazneen Rahman,et al.  Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles , 2006, Nature Genetics.

[275]  P. Tappenden,et al.  A rapid-response economic evaluation of the UK NHS Cancer Reform Strategy breast cancer screening program extension via a plausible bounds approach. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[276]  J. Sampson,et al.  A comparison of methods currently used in clinical practice to estimate familial breast cancer risks. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[277]  Jaana M. Hartikainen,et al.  Large-scale genotyping identifies 41 new loci associated with breast cancer risk , 2013, Nature Genetics.

[278]  J. Ainsworth,et al.  Breast Cancer Risk in Young Women in the National Breast Screening Programme: Implications for Applying NICE Guidelines for Additional Screening and Chemoprevention , 2014, Cancer Prevention Research.

[279]  D. Evans,et al.  Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening , 2006, Journal of Medical Genetics.

[280]  H. Glick,et al.  Cost‐effectiveness analysis of mass screening for breast cancer in Japan , 1991, Cancer.

[281]  W. Lawrence,et al.  Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status. , 2005, Journal of general internal medicine.

[282]  S. Taplin,et al.  Variation in mammographic breast density by race. , 2001, Annals of epidemiology.

[283]  S. Neuhausen,et al.  Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. , 1994, Cancer Research.

[284]  J. Chang-Claude,et al.  Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). , 2006, Journal of the National Cancer Institute.

[285]  Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England , 2010, Journal of Medical Screening.

[286]  C. J. Rosenquist,et al.  Screening mammography beginning at age 40 years , 1998, Cancer.

[287]  J. Cerhan,et al.  Association of Gain and Loss of Weight before and after Menopause with Risk of Postmenopausal Breast Cancer in the Iowa Women's Health Study , 2005, Cancer Epidemiology Biomarkers & Prevention.

[288]  D. Easton,et al.  Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. , 1995, Oncogene.

[289]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[290]  Helen Warren-Forward,et al.  Reproducibility of visual assessment on mammographic density , 2008, Breast Cancer Research and Treatment.

[291]  A. Miller,et al.  Adherence to cancer prevention guidelines and risk of breast cancer , 2014, International journal of cancer.

[292]  D Tzias,et al.  Correlation of ethnicity with breast density as assessed by Quantra™ , 2011, Breast Cancer Research.

[293]  Dae Ryong Kang,et al.  Cost‐effective mammography screening in Korea: High incidence of breast cancer in young women , 2009, Cancer science.

[294]  G J van Oortmarssen,et al.  In search of the best upper age limit for breast cancer screening. , 1995, European journal of cancer.

[295]  K. Payne,et al.  Current methodological issues in the economic assessment of personalized medicine. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[296]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[297]  N. Boyd,et al.  The quantitative analysis of mammographic densities. , 1994, Physics in medicine and biology.

[298]  M J Buxton,et al.  Modelling in economic evaluation: an unavoidable fact of life. , 1997, Health economics.

[299]  Stirling Bryan,et al.  Modelling in the economic evaluation of health care: selecting the appropriate approach , 2004, Journal of health services research & policy.

[300]  Andrew D. A. Maidment,et al.  A Comparative Study of Volumetric and Area-Based Breast Density Estimation in Digital Mammography: Results from a Screening Population , 2010, Digital Mammography / IWDM.

[301]  P. Pharoah,et al.  Prediction of pathogenic mutations in patients with early-onset breast cancer by family history , 2003, The Lancet.

[302]  Dan Rico,et al.  A volumetric method for estimation of breast density on digitized screen-film mammograms. , 2003, Medical physics.

[303]  S. Gruber,et al.  Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome , 2006, Clinical Cancer Research.

[304]  A. Howell,et al.  Central obesity and breast cancer risk: a systematic review , 2003, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[305]  N E Day,et al.  Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study , 2001, Genetic epidemiology.

[306]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.